Aramark
ARMK- Exchange
- NYSE
- Industry
- Retail-Eating Places
- SEC CIK
- 0001584509
In the last 90 days, Aramark insiders filed 0 open-market purchases and 1 sale; 550 institutions reported holding it in 13F filings for Q2 2026, worth $14.8B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:36 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Oct 3, 2025 | Sep 27, 2024 | Sep 29, 2023 | Sep 30, 2022 | Oct 1, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 17, 2025 | Nov 12, 2024 | Nov 14, 2023 | Nov 15, 2022 | Nov 16, 2021 |
| Revenue | $18.5B | $17.4B | $18.9B | $16.3B | $12.1B |
| Cost of revenue | – | – | – | $14.8B | $11.0B |
| Selling, general and administrative | $278.4M | $283.6M | $406.8M | $398.4M | $346.7M |
| Operating income | $791.8M | $706.5M | $862.9M | $628.4M | $191.4M |
| Interest expense | – | – | $441.3M | $381.5M | $413.7M |
| Income tax | $103.6M | $103.0M | $177.6M | $61.5M | -$40.6M |
| Net income | $326.4M | $262.5M | $674.1M | $194.5M | -$90.8M |
| EPS, basic | $1.24 | $1.00 | $2.59 | – | – |
| EPS, diluted | $1.22 | $0.99 | $2.57 | – | – |
| Weighted shares, basic | 263.9M | 263.0M | 260.6M | 257.3M | 254.7M |
| Weighted shares, diluted | 267.3M | 266.2M | 262.6M | 259.1M | 254.7M |
| Margins and growth | |||||
| Operating margin | 4.3% | 4.1% | 4.6% | 3.8% | 1.6% |
| Net margin | 1.8% | 1.5% | 3.6% | 1.2% | -0.8% |
| Revenue growth, year over year | +6.4% | −7.7% | +15.5% | +35.0% | −5.7% |
| Net income growth, year over year | +24.3% | −61.1% | +246.6% | – | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Oct 3, 2025 | Sep 27, 2024 | Sep 29, 2023 | Sep 30, 2022 | Oct 1, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 17, 2025 | Nov 12, 2024 | Nov 14, 2023 | Nov 15, 2022 | Nov 16, 2021 |
| Cash and equivalents | $639.1M | $672.5M | $1.96B | $329.5M | $532.6M |
| Accounts receivable | $2.21B | $2.10B | $2.36B | $2.15B | $1.75B |
| Inventory | $418.8M | $387.6M | $578.4M | $552.4M | $412.7M |
| Total current assets | $3.52B | $3.41B | $5.22B | $3.29B | $2.90B |
| Property, plant and equipment | $1.73B | $1.57B | $2.09B | $2.03B | $2.04B |
| Goodwill | $4.87B | $4.68B | $5.58B | $5.52B | $5.49B |
| Intangible assets | $1.87B | $1.80B | $2.04B | $2.11B | $2.03B |
| Total assets | $13.3B | $12.7B | $16.9B | $15.1B | $14.4B |
| Accounts payable | $1.52B | $1.39B | $1.41B | $1.32B | $919.1M |
| Short-term debt | – | – | $1.60B | $65.0M | $58.9M |
| Total current liabilities | $3.55B | $4.21B | $5.03B | $3.29B | $2.86B |
| Shareholders' equity | $3.15B | $3.04B | $3.71B | $3.03B | $2.72B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Oct 3, 2025 | Sep 27, 2024 | Sep 29, 2023 | Sep 30, 2022 | Oct 1, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 17, 2025 | Nov 12, 2024 | Nov 14, 2023 | Nov 15, 2022 | Nov 16, 2021 |
| Operating cash flow | – | – | $766.4M | $694.5M | $657.1M |
| Capital expenditures | $489.2M | $427.4M | $461.4M | $388.4M | $407.8M |
| Free cash flow | – | – | $305.0M | $306.1M | $249.3M |
| Depreciation and amortization | $476.3M | $435.5M | $546.4M | $532.3M | $550.7M |
| Stock-based compensation | $58.6M | $62.6M | $86.9M | $95.5M | $71.1M |
| Dividends paid | $110.8M | $99.9M | $114.6M | $113.1M | $112.0M |
| Share buybacks | $169.8M | – | – | $0 | $0 |
| Investing cash flow | – | – | $208.9M | -$831.3M | -$634.4M |
| Financing cash flow | – | – | $653.6M | -$37.7M | -$2.01B |
| Net change in cash | -$25.5M | -$1.24B | $1.63B | -$203.1M | -$1.98B |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.3% | 0.4% | 0.5% | 0.6% | 0.6% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Jul 31, 2026 | 263.6M | +0.3% | SEC |
| May 1, 2026 | 263.0M | +0.3% | SEC |
| Jan 30, 2026 | 262.8M | −0.9% | SEC |
| Oct 31, 2025 | 262.9M | −0.4% | SEC |
| Jul 25, 2025 | 262.9M | −0.2% | SEC |
| Apr 25, 2025 | 262.1M | −0.4% | SEC |
| Jan 24, 2025 | 265.1M | +1.0% | SEC |
| Oct 25, 2024 | 263.9M | +0.9% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.